Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology June 2018 6(6):445-454 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587